# Uvavanyo lweCalprotectin yeNdle: Utshintsho kwiParadigm kuLawulo lweZifo zeSisu

**I-Biomarker Engangenisi Unyango Eguqula Ukuxilongwa Nokujongwa Kwe-IBD**

Kwiminyaka yakutshanje, i-fecal calprotectin (FC) iye yavela njengeyona nto ibalulekileyo kwi-gastroenterology, nto leyo etshintshe kakhulu indlela isifo samathumbu esidumbayo (IBD) esichongwa ngayo nesilawulwa ngayo. Njengoko uluntu lwezonyango luqhubeka nokwamkela izixhobo zokuxilonga ezingangenisi ntsholongwane, uvavanyo lwe-FC lubalasele ngenxa yokusetyenziswa kwalo kwezonyango, luxhaswa bubungqina obandayo kunye nokwamkelwa ngokusesikweni kwizikhokelo zeklinikhi.

## Ukubaluleka kweCalprotectin kwiKliniki

ICalprotectin yiproteni ebopha icalcium ekhutshwa kakhulu yi-neutrophils esebenzayo kwi-mucosa yamathumbu ngexesha lokuvuvukala. Xa kukho ukuvuvukala, i-calprotectin ikhutshwa kwindle, nto leyo enika uphawu olulinganisekayo noluzinzileyo lokuvuvukala kwamathumbu. Indalo yayo yokungangenisi, kunye nokuzinza kohlalutyo kunye nokufaneleka kokulinganisa okuphindaphindiweyo, yenza ukuba ibe sisixhobo esixabisekileyo kunyango lwanamhlanje.

## Ukwahlula i-IBD kwi-IBS: Isicelo seKliniki esiBalulekileyo

Enye yezona ngxaki zibalulekileyo kwi-gastroenterology kukwahlula i-IBD—equka isifo sikaCrohn kunye ne-ulcerative colitis—kwi-irritable bowel syndrome (IBS). Zombini ezi meko zikho kunye neempawu ezifanayo zesisu, kodwa i-IBD ibandakanya ukudumba kwe-mucosal yendalo okufuna unyango lwe-immunosuppressive kwaye inemingcipheko yeengxaki. I-IBS, ngokuchaseneyo, sisifo esingasebenziyo ngaphandle kwe-organic pathology echongwayo.

Uvavanyo lwe-calprotectin yendle lubonakalise ukuba luxabiseke kakhulu kolu xilongo lwahlukileyo. I-biomarker ibonisa ukuba umntu uvakalelwa yi-95% kwaye ucacile yi-91% xa ehlula izigulane ze-IBD kwiindlela eziphilileyo. Olu xilongo luvumela oogqirha ukuba bahlole izigulane ngokufanelekileyo, bechonga abo bafuna uvavanyo lwe-endoscopic ngelixa benciphisa iinkqubo ezingafunekiyo zokungenelela kwizigulane ezineengxaki zokusebenza. Izikhokelo zeklinikhi zika-2025 ezivela kwi-American College of Gastroenterology zivumile ukuba i-calprotectin yendle inqunyulwe yi->50–100 mg/g ukwahlula isifo esivuthayo nesingesiso isifo.

## Ukuvavanya Umsebenzi Wesifo kunye Nonyango Olukhokelayo

Ngaphaya kokuchongwa, uvavanyo lwe-FC lubonakalise uncedo olukhulu ekujongeni umsebenzi wesifo kunye nokuvavanya impendulo yonyango. Uphando oluvela kwiMayo Clinic luseke ulwalamano oluphezulu nolubalulekileyo ngokwezibalo phakathi kwamanqanaba e-FC kunye namanqaku angaphantsi kwe-endoscopic kwizigulane ezine-ulcerative colitis, nto leyo ebonisa ukuba i-FC inokusebenza njengophawu oluthembekileyo nolunobuthathaka kakhulu lokudumba kwe-endoscopic. Ngokukodwa, i-FC cutoff ye-60 mcg/g yahlula ngokufanelekileyo ukukhululwa kwe-endoscopic kwisifo esisebenzayo, ngelixa imilinganiselo ephezulu yayixela ukudumba okunzulu ngakumbi.

Ezi ziphumo zinefuthe elikhulu kwindlela yokusebenza kwezonyango. Ukukwazi ukujonga ukusebenza kwesifo ngovavanyo olulula lwesitulo, endaweni yovavanyo oluphindaphindwayo lwe-endoscopy, kunika oogqirha isixhobo esisebenzayo nesingabizi kakhulu sokulungisa unyango.

Uvavanyo olukhawulezayo lweBaysen lunokubonelela ngovavanyo lwe-calprotectin ngovavanyo olusemgangathweni nolunobungakanani. Wamkelekile kumbuzo!